55513-0224 Riabni - CanMED: NDC

Product NDC:

55513-0224

Brand Name:

Riabni

Generic Name:

Rituximab-arrx

Dosage Form Name:

INJECTION, SOLUTION

Administration Route:

Intravenous

Substances:

Name: RITUXIMAB

Strength: 100.0

Unit: mg/10mL

Packages:

Code: 55513-0224-01

Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (55513-224-01) / 10 mL in 1 VIAL, SINGLE-DOSE

Effective Date: Jan. 6, 2021

Discontinued:

Code: 55513-0224-21

Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (55513-224-21) / 10 mL in 1 VIAL, SINGLE-DOSE

Effective Date: July 21, 2025

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Monoclonal Antibody

Minor Class:

CD20

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox